IntroductionCommunity engagement has been considered a fundamental component of past outbreaks, such as Ebola. However, there is concern over the lack of involvement of communities and ‘bottom-up’ approaches used within COVID-19 responses thus far. Identifying how community engagement approaches have been used in past epidemics may support more robust implementation within the COVID-19 response.MethodologyA rapid evidence review was conducted to identify how community engagement is used for infectious disease prevention and control during epidemics. Three databases were searched in addition to extensive snowballing for grey literature. Previous epidemics were limited to Ebola, Zika, SARS, Middle East respiratory syndromeand H1N1 since 2000. No restrictions were applied to study design or language.ResultsFrom 1112 references identified, 32 articles met our inclusion criteria, which detail 37 initiatives. Six main community engagement actors were identified: local leaders, community and faith-based organisations, community groups, health facility committees, individuals and key stakeholders. These worked on different functions: designing and planning, community entry and trust building, social and behaviour change communication, risk communication, surveillance and tracing, and logistics and administration.ConclusionCOVID-19’s global presence and social transmission pathways require social and community responses. This may be particularly important to reach marginalised populations and to support equity-informed responses. Aligning previous community engagement experience with current COVID-19 community-based strategy recommendations highlights how communities can play important and active roles in prevention and control. Countries worldwide are encouraged to assess existing community engagement structures and use community engagement approaches to support contextually specific, acceptable and appropriate COVID-19 prevention and control measures.

Introduction Community engagement has been considered a fundamental component of past outbreaks, such as Ebola. The COVID-19 pandemic and its control efforts require social actions and behaviours, all of which place a large reliance on individual and community compliance, highlighting the need for appropriate community engagement to support such work. However, there is concern over the lack of involvement of communities within COVID-19 thus far. Identifying how community engagement approaches have been used in past epidemics may support more robust implementation of community engagement within COVID-19 response. Methodology A rapid evidence review was conducted to identity how community engagement is used for infectious disease prevention and control during epidemics. Three databases (PubMed, CINHAL and Scopus) were searched in addition to extensive snowballing for grey literature. Previous epidemics were limited to Ebola, Zika, SARS, MERS and H1N1 since 2000. No restrictions were applied to study design or language, though articles must have detailed a minimum of one community engagement for infection prevention and control initiative. All authors participated in searching, screening, and data extraction, with a minimum of two authors at each stage. Results From 1,112 references identified in our search, 32 articles met our inclusion criteria. All but 3 articles were published on or after 2015 which details 37 community engagement initiatives for Ebola (n=28), Zika (n=5) and H1N1 (n=4). Twenty-seven of these initiatives were implemented in low-income countries and 10 from high-income countries. Six broad community engagement actors were identified: local leaders, community and faith-based organisations, community groups, health facility or community health committees, individuals and key stakeholders. These actors worked across six different functions: designing and planning, community entry and trust-building, social and behaviour change communication, risk communication, surveillance and tracing, and logistics and administration. Leaders were the most prevalent actor being engaged, and behaviour change communication, risk communication, and surveillance and tracing were the most common function of community engagement. Implementation considerations community engagement in prevention and control of COVID-19 are reported within. Conclusion COVID-19 global presence and social transmission pathways require social and community responses. This may be particularly important to reach marginalised populations and support equity-informed responses. Previous experience from outbreaks shows that community engagement can take many forms and include different actors and approaches who support various prevention and control activities. Countries worldwide are encouraged to assess existing community engagement structures, and utilise community engagement approaches to support contextually specific, acceptable and appropriate COVID-19 prevention and control measures.

IntroductionWidespread vaccination against COVID-19 is one of the most effective ways to control, and ideally, end the global COVID-19 pandemic. Vaccine hesitancy and vaccine rates vary widely across countries and populations and are influenced by complex sociocultural, political, economic and psychological factors. Community engagement is an integral strategy within immunisation campaigns and has been shown to improve vaccine acceptance. As evidence on community engagement to support COVID-19 vaccine uptake is emerging and constantly changing, research that lessens the knowledge-to-practice gap by providing regular and up-to-date evidence on current best-practice is essential.Methods and analysisA living systematic review will be conducted which includes an initial systematic review and bimonthly review updates. Searching and screening for the review and subsequent updates will be done in four streams: a systematic search of six databases, grey literature review, preprint review and citizen sourcing. The screening will be done by a minimum of two reviewers at title/abstract and full-text in Covidence, a systematic review management software. Data will be extracted across predefined fields in an excel spreadsheet that includes information about article characteristics, context and population, community engagement approaches, and outcomes. Synthesis will occur using the convergent integrated approach. We will explore the potential to quantitatively synthesise primary outcomes depending on heterogeneity of the studies.Ethics and disseminationThe initial review and subsequent bimonthly searches and their results will be disseminated transparently via open-access methods. Quarterly briefs will be shared on the reviews’ social media platforms and across other interested networks and repositories. A dedicated web link will be created on the Community Health-Community of Practice site for sharing findings and obtaining feedback. A mailing list will be developed and interested parties can subscribe for updates.PROSPERO registration numberCRD42022301996.

Background Widespread vaccination against Coronavirus Disease 2019 (COVID-19) is one of the most effective ways to control, and ideally, end the global COVID-19 pandemic. Vaccine hesitancy and vaccine rates vary widely across countries and populations and are influenced by complex socio-cultural, political, economic, and psychological factors. Community engagement is an integral strategy within immunisation campaigns and has been shown to improve vaccine acceptance. As evidence on community engagement to support COVID-19 vaccine uptake is emerging, this review aims to lessen the knowledge-to-practice gap by providing regular evidence on current best-practice. Methodology A living systematic review will be conducted which includes an initial systematic review and bi-monthly review updates. Searching and screening for the review and subsequent updates will be done in four streams: a systematic search of six databases, grey literature review, preprint review, and citizen sourcing. All returned articles will be collated into Covidence, where screening will be done by a minimum of two reviewers at title/abstract and full-text. Data will be extracted across pre-defined data extraction tables, and synthesis will occur using the convergent integrated approach. Updates to the review resulting from the subsequent bi-monthly searches will be shared in an open-access platform. The protocol has been registered with PROSPERO: CRD42022301996. Discussion Given the variation in vaccination rates across different contexts and the recognition that high vaccination coverage is required to reduce COVID-19 transmission and to stop the emergence of new variants, it is imperative the global community implements strategies that will improve uptake and that this work is widely shared and contextualised. Community engagement to promote vaccine uptake is highly encouraged, and recent studies highlight its potential to influence vaccine rates, particularly across populations that are marginalised. The high-priority research needed on this topic, and the rapidly changing evidence base, supports the conduct of a living systematic review.